Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Nature Reviews. Clinical Oncology
|
June 5, 2024
Exploiting bacteria for cancer immunotherapy
Seong-Young Kwon, Hien Thi-Thu Ngo, Jinbae Son, et al.
Cell Communication and Signaling : CCS
|
November 26, 2022
Intracellular cholesterol transport inhibition Impairs autophagy flux by decreasing autophagosome-lysosome fusion
Yunash Maharjan, Raghbendra Kumar Dutta, Jinbae Son, et al.
Plos One
|
February 19, 2021
Pharmacological inhibition of catalase induces peroxisome leakage and suppression of LPS induced inflammatory response in Raw 264.7 cell
Yizhu Mu, Yunash Maharjan, Raghbendra Kumar Dutta, et al.
International Journal of Molecular Sciences
|
January 25, 2017
The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
Shunfei Yan, Daniel Frank, Jinbae Son, et al.
Pharmaceutics
|
December 23, 2022
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2020
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Jinbae Son, Katherine M Hannan, Gretchen Poortinga, et al.
Communications Biology
|
February 1, 2019
Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation
Jeannine Diesch, Megan J Bywater, Elaine Sanij, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 20, 2018
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
Maheshi Udugama, Elaine Sanij, Hsiao P J Voon, et al.
Nature Communications
|
May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Elaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Nature Reviews. Clinical Oncology
|
June 5, 2024
Exploiting bacteria for cancer immunotherapy
Seong-Young Kwon, Hien Thi-Thu Ngo, Jinbae Son, et al.
Cell Communication and Signaling : CCS
|
November 26, 2022
Intracellular cholesterol transport inhibition Impairs autophagy flux by decreasing autophagosome-lysosome fusion
Yunash Maharjan, Raghbendra Kumar Dutta, Jinbae Son, et al.
Plos One
|
February 19, 2021
Pharmacological inhibition of catalase induces peroxisome leakage and suppression of LPS induced inflammatory response in Raw 264.7 cell
Yizhu Mu, Yunash Maharjan, Raghbendra Kumar Dutta, et al.
International Journal of Molecular Sciences
|
January 25, 2017
The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
Shunfei Yan, Daniel Frank, Jinbae Son, et al.
Pharmaceutics
|
December 23, 2022
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, et al.
Frontiers in Cell and Developmental Biology
|
July 29, 2020
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
Jinbae Son, Katherine M Hannan, Gretchen Poortinga, et al.
Communications Biology
|
February 1, 2019
Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation
Jeannine Diesch, Megan J Bywater, Elaine Sanij, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 20, 2018
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
Maheshi Udugama, Elaine Sanij, Hsiao P J Voon, et al.
Nature Communications
|
May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Elaine Sanij, Katherine M Hannan, Jiachen Xuan, et al.
Page
of 1